CFB
ASND icon

Cullen/Frost Bankers’s Ascendis Pharma A/S ASND Stock Holding History

Cullen/Frost Bankers’s Portfolio ASND Stock Details ASND Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$10.8K Hold
47
– – ﹤0.01% 1097
2025
Q4 		$10K Buy
47
+2
+4% +$413 ﹤0.01% 1115
2025
Q3 		$8.95K Hold
45
– – ﹤0.01% 1095
2025
Q2 		$7.77K Hold
45
– – ﹤0.01% 1059
2025
Q1 		$7.01K Buy
45
+4
+10% +$571 ﹤0.01% 1001
2024
Q4 		$5.64K Hold
41
– – ﹤0.01% 979
2024
Q3 		$6.12K Buy
41
+38
+1,267% +$5.13K ﹤0.01% 959
2024
Q2 		$409 Buy
+3
New +$408 ﹤0.01% 1213
2024
Q1 		– Sell
-100
Closed -$12.6K – 1001
2023
Q4 		$12.6K Hold
100
– – ﹤0.01% 789
2023
Q3 		$9.36K Buy
+100
New +$9.36K ﹤0.01% 932

Other funds holding ASND

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $61.3B AUM 26.25% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return